Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, ...
The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...
Exploring eQTL studies as a cornerstone in deciphering the genetic architecture of gene regulation Understanding the genetic ...
New Study Shows SIK1 Strengthens Antiviral Immunity to Limit EV-D68–Induced Asthma Exacerbations Asthma is a chronic ...
Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...
Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 ...
Venetia Zachariou, PhD, Edward Avedisian Professor and chair of pharmacology, physiology & biophysics at Boston University Chobanian & Avedisian School of Medicine, has been named a Class of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback